As of Jan 19
| -1.75 / -4.52%|
The 3 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 47.00, with a high estimate of 55.00 and a low estimate of 43.00. The median estimate represents a +27.03% increase from the last price of 37.00.
The current consensus among 4 polled investment analysts is to Buy stock in Natus Medical Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.